Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

NAEnrolling by invitationINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Prostatic Neoplasms
Interventions
PROCEDURE

multiparametric MRI Diagnostics

Patients with newly diagnosed prostate cancer enrolled in active surveillance following standard protocol including PSA, DRE and TRUS biopsies and intervention with multiparametric MRI + additional biopsies if suspicious lesions are found

Trial Locations (1)

2730

Department of Urology, Herlev University Hospital Herlev, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER